Show simple item record

dc.contributor.authorGandhi, A
dc.contributor.authorRanganathan, B
dc.contributor.authorThiryayi, S A
dc.contributor.authorRowland, M
dc.contributor.authorYap, Beng K
dc.date.accessioned2015-07-01T07:54:51Zen
dc.date.available2015-07-01T07:54:51Zen
dc.date.issued2015-04-30en
dc.identifier.citationVariations in single/two stage thyroidectomies for cancer may be due to differences in thyroid fine needle cytology provision. 2015: Eur J Surg Oncolen
dc.identifier.issn1532-2157en
dc.identifier.pmid25983241en
dc.identifier.doi10.1016/j.ejso.2015.04.010en
dc.identifier.urihttp://hdl.handle.net/10541/558731en
dc.description.abstractRecommended treatment for thyroid cancers >10 mm is single stage total thyroidectomy (SST). Cancers diagnosed by diagnostic lobectomy may need completion surgery resulting in two stage thyroidectomies (TST). We noticed significant variation in numbers of SST and TST between hospitals within our cancer network and explored reasons for this using a prospective database containing all cases from 2004 to 2011 (n = 1030). We therefore conducted a survey of thyroid cytology provision across the network during 2010-2011.
dc.languageENGen
dc.language.isoenen
dc.rightsArchived with thanks to European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncologyen
dc.titleVariations in single/two stage thyroidectomies for cancer may be due to differences in thyroid fine needle cytology provision.en
dc.typeArticleen
dc.contributor.departmentUniversity of Manchester, Manchester Academic Health Sciences Centre, University Hospital of South Manchester, Manchester, UKen
dc.identifier.journalEuropean Journal of Surgical Oncologyen
html.description.abstractRecommended treatment for thyroid cancers >10 mm is single stage total thyroidectomy (SST). Cancers diagnosed by diagnostic lobectomy may need completion surgery resulting in two stage thyroidectomies (TST). We noticed significant variation in numbers of SST and TST between hospitals within our cancer network and explored reasons for this using a prospective database containing all cases from 2004 to 2011 (n = 1030). We therefore conducted a survey of thyroid cytology provision across the network during 2010-2011.


Files in this item

This item appears in the following Collection(s)

Show simple item record